Jayempi

Azathioprine, the active ingredient in Jayempi, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent organ rejection and to manage autoimmune conditions such as rheumatoid arthritis, inflammatory bowel disease, and autoimmune hepatitis. It belongs to the antimetabolite class and works by interfering with DNA synthesis in rapidly dividing immune cells.

GNH USA supplies Jayempi as a licensed, GDP‑compliant international pharmaceutical supplier, providing high‑quality medicines to hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with robust quality assurance and regulatory adherence.

Azathioprine is used to modulate immune activity in several chronic conditions.

- Organ transplantation: helps prevent graft rejection by suppressing T‑cell activation. - Rheumatoid arthritis: reduces joint inflammation and disease progression in patients with moderate to severe disease. - Inflammatory bowel disease: induces and maintains remission in Crohn’s disease and ulcerative colitis. - Autoimmune hepatitis: controls hepatic inflammation and improves liver function in autoimmune‑mediated hepatitis.

Azathioprine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting - Loss of appetite - Fatigue - Mild leukopenia

Serious or Rare Side Effects: - Severe bone marrow suppression (agranulocytosis) - Hepatotoxicity with elevated liver enzymes - Increased risk of opportunistic infections - Pancreatitis - Possible malignancies such as lymphoma

When prescribing azathioprine, clinicians should observe several safety measures to minimize risks.

- Monitor blood counts: perform regular complete blood count tests to detect leukopenia or anemia. - Assess liver function: conduct periodic liver enzyme tests to identify hepatotoxicity early. - Avoid live vaccines: patients on azathioprine should not receive live attenuated vaccines due to impaired immunity. - Use effective contraception: azathioprine is contraindicated in pregnancy (Category D) and requires reliable birth control for both sexes. - Adjust dose in renal/hepatic impairment: reduce dosage according to renal or hepatic function to prevent accumulation. - Store at room temperature: keep tablets in the original container, protect from moisture and heat.

Azathioprine interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid): - Allopurinol or febuxostat: may markedly increase azathioprine toxicity, requiring dose reduction or avoidance. - Warfarin: azathioprine can enhance anticoagulant effect, increasing bleeding risk. - Live viral vaccines: concurrent use can lead to severe infection.

Moderate Interactions (Monitor Closely): - ACE inhibitors and ARBs: may increase risk of renal dysfunction when combined with azathioprine. - NSAIDs: can exacerbate gastrointestinal irritation and affect renal function. - Sulfonamide antibiotics (e.g., trimethoprim‑sulfamethoxazole): may increase bone marrow suppression. - Ribavirin: may potentiate hematologic toxicity.